Skip to main content
WCS
Menu
Library
Library Catalog
eJournals & eBooks
WCS Research
Archives
Research Use
Finding Aids
Digital Collections
WCS History
WCS Research
Research Publications
Science Data
Services for WCS Researchers
Archives Shop
Bronx Zoo
Department of Tropical Research
Browse By Product
About Us
FAQs
Intern or Volunteer
Staff
Donate
Search WCS.org
Search
search
Popular Search Terms
WCS History
Library and Archives
Library and Archives Menu
Library
Archives
WCS Research
Archives Shop
About Us
Donate
en
fr
Title
Diclofenac residues in carcasses of domestic ungulates available to vultures in India
Author(s)
Taggart M.A., Senacha K.R., Green R.E., Jhala Y.V., Raghavan B., Rahmani A.R., Cuthbert R., Pain D.J., Meharg A.A.
Published
2007
Publisher
Environment International
Published Version DOI
https://doi.org/10.1016/j.envint.2007.02.010
Abstract
Gyps vulture populations across the Indian subcontinent are declining rapidly and evidence indicates that veterinary use of the non-steroidal anti-inflammatory drug (NSAID) diclofenac is the major cause. Exposure of vultures to diclofenac is likely to arise from the consumption of livestock carcasses that have been treated shortly before death, however, detailed information regarding the prevalence and residual levels of diclofenac in carcasses available to vultures in India remains unreported. Here, we present data on diclofenac residues in 1848 liver samples taken from carcasses of dead livestock sampled at 67 sites in 12 states within India, between May 2004 and July 2005. Diclofenac residues were detected in carcasses in all states except Orisa, where only one site was sampled. The overall prevalence of detectable diclofenac (> 10 µg kg- 1) across all states was 10.1% and varied significantly among states, with up to 22.3% prevalence determined in Bihar. The geometric mean concentration of diclofenac found in samples in which the drug was detected was 352 µg kg- 1. The prevalence of carcasses containing diclofenac is similar to that previously proposed to be required to have caused the observed Gyps vulture declines in India. On the 11th of May 2006, the Drug Controller General (India) ordered the withdrawal of all licenses granted for the manufacture of diclofenac for veterinary use within India. However, if Gyps vultures are to be protected, potentially substantial existing stocks now need to be quickly and effectively removed from the Indian veterinary market. © 2007 Elsevier Ltd. All rights reserved.
Keywords
Drug products; Medical problems; Nitrogen compounds; Population dynamics; Death; Residual levels; Vultures; Birds; diclofenac; drug residue; bird; drug; livestock; population decline; species conservation; ungulate; animal tissue; article; carcass; female; India; liver; livestock; male; nonhuman; priority journal; ungulate; veterinary medicine; Animals; Animals, Domestic; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Diclofenac; Falconiformes; Feeding Behavior; Female; India; Male; Asia; Bihar; Eurasia; India; Orissa; South Asia; Gyps; Ungulata
Access Full Text
A full-text copy of this article may be available. Please email the
WCS Library
to request.
Back
PUB12097